Brittany Hagedorn

Research Scientist




Brittany Hagedorn is a financial analyst for the Institute for Disease Modeling. She collaborates with multiple disease teams to estimate the cost of proposed interventions and to assess their value in comparison to alternative strategies for disease control. Brittany is interested in questions around the value of information in helping policy makers design more cost-effective strategies, as well as the trade-offs between alternative intervention strategies under budgetary constraints. Prior to joining IDM, Brittany worked with North American healthcare delivery systems to optimize their workflows to improve safety and clinical outcomes while simultaneously reducing cost. She has also advised healthcare technology companies on product design and development. Brittany is an ASQ-certified Six Sigma Black Belt and holds a B.S. in Systems Engineering and Masters of Business Administration (MBA) from Washington University in St. Louis.

Preferred Pronouns

Personal Academic Website

Research/Topics of Interest

Pathogens/Diseases of Main Interest/Expertise

Countries of Work/Collaboration



Frey K, Hagedorn B, McCarthy KA, Hutubessy R, Wang SA. (2022). Modeling anticipated changes in numbers of SARS-CoV-2 infections within communities due to immunization campaigns. Gates open research, (6)

Kerr CC, Stuart RM, Mistry D, Abeysuriya RG, Rosenfeld K, Hart GR, Núñez RC, Cohen JA, Selvaraj P, Hagedorn B, George L, Jastrzębski M, Izzo AS, Fowler G, Palmer A, Delport D, Scott N, Kelly SL, Bennette CS, Wagner BG, Chang ST, Oron AP, Wenger EA, Panovska-Griffiths J, Famulare M, Klein DJ. (2021). Covasim: An agent-based model of COVID-19 dynamics and interventions. PLoS computational biology, 17(7)

Van Gordon MM, McCarthy KA, Proctor JL, Hagedorn BL. (2021). Evaluating COVID-19 reporting data in the context of testing strategies across 31 low- and middle-income countries. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (110)

Kerr CC, Mistry D, Stuart RM, Rosenfeld K, Hart GR, Núñez RC, Cohen JA, Selvaraj P, Abeysuriya RG, Jastrzębski M, George L, Hagedorn B, Panovska-Griffiths J, Fagalde M, Duchin J, Famulare M, Klein DJ. (2021). Controlling COVID-19 via test-trace-quarantine. Nature communications, 12(1)

Skrip LA, Selvaraj P, Hagedorn B, Ouédraogo AL, Noori N, Orcutt A, Mistry D, Bedson J, Hébert-Dufresne L, Scarpino SV, Althouse BM. (2021). Seeding COVID-19 across Sub-Saharan Africa: An Analysis of Reported Importation Events across 49 Countries. The American journal of tropical medicine and hygiene

Skrip L, Derra K, Kaboré M, Noori N, Gansané A, Valéa I, Tinto H, Brice BW, Gordon MV, Hagedorn B, Hien H, Althouse BM, Wenger EA, Ouedraogo AL. (2020). Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (101)

Bousema T, Selvaraj P, Djimde AA, Yakar D, Hagedorn B, Pratt A, Barret D, Whitfield K, Cohen JM. (2020). Reducing the Carbon Footprint of Academic Conferences: The Example of the American Society of Tropical Medicine and Hygiene. The American journal of tropical medicine and hygiene, 103(5)

Hagedorn BL, Gauld J, Feasey N, Hu H. (2020). Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine. Vaccine, 38(7)

Wedlock PT, Mitgang EA, Oron AP, Hagedorn BL, Leonard J, Brown ST, Bakal J, Siegmund SS, Lee BY. (2019). Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines. Vaccine, 37(17)

Hagedorn BL, Dabbagh A, McCarthy KA. (2019). The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns. Vaccine, 37(41)

Zimmermann M, Hagedorn B, Lyons H. (2020). Projection of Costs of Polio Eradication Compared to Permanent Control. The Journal of infectious diseases, 221(4)

Zimmermann M, Frey K, Hagedorn B, Oteri AJ, Yahya A, Hamisu M, Mogekwu F, Shuaib F, McCarthy KA, Chabot-Couture G. (2019). Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis. Vaccine, 37(41)

If you’d like to update your profile, please email modifications to

This site is registered on as a development site.